As reviewed in this study, acute or repeated treatment with GLP-1 receptor (GLP-1R) agonists decreases alcohol consumption in rodents
Plasma DPP-4 activity, active GLP-1, body weight, and plasma TG after a 5-hour fast ( A , C , E , and G ) and plasma TG, AUC over 180 minutes, and plasma levels of active GLP-1 before and 10 minutes after oral gavage of olive oil ( B , D , F , and H ) during a lipid tolerance test (LTT) in 16- to 19-week-old Dpp4 / vs
The medication follows a gradual titration schedule, starting at 0.25 mg weekly and increasing incrementally over 1620 weeks to the maintenance dose of 2.4 mg weekly
As a matter of fact, I get asked this question almost every day
Lets keep it simple
The one-week half-life means full therapeutic effects develop gradually over several weeks after starting or adjusting doses